Company Linc AB

Equities

LINC

SE0015949433

Investment Management & Fund Operators

Market Closed - Nasdaq Stockholm Other stock markets 11:29:55 2024-04-19 am EDT			5-day change	1st Jan Change
63.9 ^SEK	0.00%		+3.23%	-1.08%

Jan. 25	Linc AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	CI
Jan. 25	Linc AB Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Business Summary

Linc Invest AB is a Sweden-based investment company. Linc invests in product-oriented companies within the Nordic Life Science industry - primarily in pharmaceutical and medical technology companies. The investments are made in both private and public companies and in research and operational companies. Typically, investments in drug development take place in an earlier phase compared to investments in medical technology. Linc Invest is an active and long-term owner with a wide industrial network to support the portfolio companies. The Company works together with the management, founders and board to realize the inherent potential that exists in the investment, have ambitious plans for further development and expansion and actively participate in the nomination committee work.

Number of employees: 2

Sales per Business

SEK in Million	2022	Weight	2023	Weight	Delta
Quoted Holding 99.9 %	2	28.2 %	4	99.9 %	+79.27%
Unallocated Items 0.1 %	5	67.2 %	0	0.1 %	-99.92%

Sales per region

SEK in Million	2022	Weight	2023	Weight	Delta
Sweden 100.0 %	7	100.0 %	4	100.0 %	-49.47%

Managers

Managers	Title	Age	Since
Snickar Karl Johan Tobieson CEO	Chief Executive Officer	50	19-12-31
Thomas Bergh DFI	Director of Finance/CFO	42	19-12-31

Members of the board

Members of the board	Title	Age	Since
Bengt Åke Julander FOU	Founder	71	90-12-31
Ulrika Dellby BRD	Director/Board Member	58	19-12-31
Marianne Dicander Alexandersson BRD	Director/Board Member	65	19-12-31
Anders Hansen BRD	Director/Board Member	50	19-12-31

Share class

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	57,910,447	21,789,252 ( 37.63 %)	0	37.63 %

Shareholders

Name	Equities	%	Valuation
Bengt Åke Julander 58.23 %	33,721,195	58.23 %	197 M kr
Nordea Investment Management AB 4.853 %	2,810,353	4.853 %	16 M kr
Enter Fonder AB 4.796 %	2,777,628	4.796 %	16 M kr
Swedbank Robur Fonder AB 4.055 %	2,348,507	4.055 %	14 M kr
Snickar Karl Johan Tobieson 3.454 %	2,000,000	3.454 %	12 M kr
Danica Pension, Livsforsikringsaktieselskab 1.933 %	1,119,690	1.933 %	7 M kr
Thomas Bergh 1.727 %	1,000,000	1.727 %	6 M kr
Anders Hansen 0.5180 %	300,000	0.5180 %	2 M kr
Ulrika Dellby 0.3454 %	200,000	0.3454 %	1 M kr
Marianne Dicander Alexandersson 0.1727 %	100,000	0.1727 %	585 452 kr

Holdings

Name	Equities	%	Valuation
MEDCAP AB 20.03%	2,965,946	20.03%	105,960,319 $
CALLIDITAS THERAPEUTICS AB 10.01%	5,963,966	10.01%	63,250,662 $
STILLE AB 21.62%	1,942,585	21.62%	32,701,612 $
SEDANA MEDICAL AB 10.18%	10,111,030	10.18%	15,139,245 $
C-RAD AB 7.78%	2,558,375	7.78%	10,264,508 $
OSSDSIGN AB 5.37%	5,242,896	5.37%	4,952,335 $
EGETIS THERAPEUTICS AB 2.57%	7,532,021	2.57%	4,705,479 $
FLUOGUIDE A/S 6.97%	850,046	6.97%	3,792,081 $